Patents by Inventor Vida J. Gorys

Vida J. Gorys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis C inhibitor compounds
    Patent number: 8067438
    Abstract: Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: November 29, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Murray Douglas Bailey, Punit R. Bhardwaj, Josee Bordeleau, Pasquale Forgione, Elise Ghiro, Vida J. Gorys, Nathalie Goudreau, Sylvie Goulet, Teddy Halmos, Jean Rancourt
  • Macrocyclic peptides active against the hepatitis C virus
    Patent number: 7119072
    Abstract: Compounds of formula I: wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O(C1-6)alkyl, amido, amino or phenyl; R2 is (C5-6)cycloalkyl and R3 is cyclopentyl; or a pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: October 10, 2006
    Assignee: Boehringer Ingelheim (Canada) Ltd.
    Inventors: Montse Llinas-Brunet, Vida J. Gorys
  • Macrocyclic peptides active against the hepatitis C virus
    Publication number: 20030224977
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: January 29, 2003
    Publication date: December 4, 2003
    Applicant: Boehringer Ingelheim (Canada) Ltd.
    Inventors: Montse Llinas-Brunet, Vida J. Gorys
  • Hepatitis C inhibitor tri-peptides
    Patent number: 6642204
    Abstract: Disclosed herein are compounds of formula (1): wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O—(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O—(C1-6) alkyl, amido, amino or phenyl; R2 is (C4-6)cycloalkyl; R3 is t-butyl or (C5-6) cycloalkyl and R4 is (C4-6)cycloalkyl; or a pharmaceutically acceptable salt thereof. The compounds are useful as inhibitors of HCV NS3 protease.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: November 4, 2003
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Vida J. Gorys
  • Hepatitis C inhibitor tri-peptides
    Publication number: 20030187018
    Abstract: Disclosed herein are compounds of formula (1): 1
    Type: Application
    Filed: January 29, 2003
    Publication date: October 2, 2003
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Montse Llinas-Brunet, Vida J. Gorys
  • Macrocyclic peptides active against the hepatitis C virus
    Publication number: 20030181363
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: December 17, 2002
    Publication date: September 25, 2003
    Applicant: Boehringer Ingelheim (Canada) Ltd.
    Inventors: Montse Llinas-Brunet, Vida J. Gorys